
Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip®) to adults aged ≥60
Keywords: FHA, filamentous haemagglutinin; FIM, fimbriae; GMT, geometric mean titre; PRN, pertactin; PT, pertussis toxoid; Tdap-IPV, diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccineElderly; Immune response; Inactivated influenza vaccin